Is serum gentamicin concentration modified with autologous cell-saved blood transfusion after total knee arthroplasty using tranexamic acid? A randomised control trial

Orthopaedics and Traumatology: Surgery and Research

Volumn 107, Issue 3, 2021, Pages

  Touzopoulos, Panagiotis ^a   Arvanitidis, Konstantinos ^b   Filidou, Eirini ^b   Tilkeridis, Konstantinos ^b   Karanikas, Michael ^b   Kolios, George ^b   Ververidis, Athanasios ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Blood loss; Gentamicin; Self transfusion; Total knee; Toxicity; Tranexamic acid

Indexed keywords

CREATININE; GENTAMICIN; HEMOGLOBIN; PALACOS; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; PATIENT SAFETY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; TOTAL KNEE ARTHROPLASTY; TREATMENT OUTCOME; ADVERSE EVENT; BLOOD TRANSFUSION; KNEE REPLACEMENT; POSTOPERATIVE HEMORRHAGE;

ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; GENTAMICINS; HUMANS; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID;

EID: 85098597517     PISSN: None     EISSN: 18770568     Source Type: Journal    
DOI: 10.1016/j.otsr.2020.102794     Document Type: Article

References (37)

1. Cram, P., Lu, X., Kates, S.L., Singh, J.A., Li, Y., et al. Total knee arthroplasty volume, utilisation, and outcomes among Medicare beneficiaries, 1991–2010. JAMA 308 (2012), 1227–1236.
2. Jaeblon, T., Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J Am Acad Orthop Surg 18 (2010), 297–305.
3. Kalil, G.Z., Ernst, E.J., Johnson, S.J., Johannsson, B., Polgreen, P.M., Bertolatus, J.A., et al. Systemic exposure to aminoglycosides following knee and hip arthroplasty with aminoglycoside-loaded bone cement implants. Ann Pharmacother 46 (2012), 929–934.
4. Randelli, P., Evola, F.R., Cabitza, P., Polli, L., Denti, M., et al. Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 18 (2010), 181–186.
5. Wang, J., Zhu, C., Cheng, T., Peng, X., Zhang, W., Qin, H., et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One, 8, 2013, e82745.
6. Slappendel, R., Dirksen, R., Weber, E.W., van der Schaaf, D.B., An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 74 (2003), 569–575.
7. Pawaskar, A., Salunke, A.A., Kekatpure, A., Chen, Y., Nambi, G.I., Tan, J., et al. Do autologous blood transfusion systems reduce allogeneic blood transfusion in total knee arthroplasty?. Knee Surg Sports Traumatol Arthrosc 25 (2016), 2957–2966.
8. Carson, J.L., Hill, S., Carless, P., Hébert, P., Henry, D., Transfusion triggers: a systematic review of the literature. Transfus Med Rev 16 (2002), 187–199.
9. American Society of Anesthesiologists., Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84 (1996), 732–747.
10. Nadler, S.B., Hidalgo, J.U., Bloch, T., Prediction of blood volume in normal human adults. Surgery 51 (1962), 224–232.
11. Bourke, D.L., Smith, T.C., Estimating allowable haemodilution. Anaesthesiology 41 (1974), 609–612.
12. Sehat, K.R., Evans, R.L., Newman, J.H., Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 86 (2004), 561–566.
13. Brunetal, L., Segui, A., Cormier, M., Percheron, E., Langlais, F., Release of gentamicin from acrylic bone cement. Clin Pharmacokinetics 17 (1989), 291–297.
14. Sôrensen, T.B., Andersen, M.R., Glenthøj, J., Petersen, O., Pharmacokinetics of topical gentamicin in total hip arthroplasty. Acta Orthop Scand 55 (1984), 156–159.
15. Kellgren, J., Lawrence, J., Radiological assessment of osteoarthosis. Ann Rheum Dis 16 (1957), 494–502.
16. Patrick, B.N., Rivey, M.P., Allington, D.R., Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 40 (2006), 2037–2042.
17. Curtis, J.M., Sternhagen, V., Batts, D., Acute renal failure after placement of tobramycin-impregnated bone cement in an infected total knee arthroplasty. Pharmacotherapy 25 (2005), 876–880.
18. de Klaver, P., Hendriks, J., van Onzenoort, H., Schreurs, B., Touw, D., Derijks, L., Gentamicin serum concentrations in patients with gentamicin-PMMA beads for infected hip joints: a prospective observational cohort study. Ther Drug Monit 34 (2012), 67–71.
19. Dahlgren, J.G., Anderson, E.T., Hewitt, W.L., Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents Chemother 8 (1975), 58–62.
20. Jämsen, E., Huhtala, H., Puolakka, T., Moilanen, T., Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 91 (2009), 38–47.
21. Engesaeter, L.B., Espehaug, B., Lie, S.A., Furnes, O., Havelin, L.I., Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0–16 years in the Norwegian arthroplasty register. Acta Orthop 77 (2006), 351–358.
22. Dale, H., Hallan, G., Hallan, G., Espehaug, B., Havelin, L.I., Engesaeter, L.B., Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 80 (2009), 639–645.
23. Bohm, E., Zhu, N., Gu, J., de Guia, N., Linton, C., Anderson, T., et al. Does adding antibiotics to cement reduce the need for early revision in total knee arthroplasty?. Clin Orthop Relat Res 472 (2014), 162–168.
24. Parvizi, J., Saleh, K.J., Ragland, P.S., Pour, A.E., Mont, M.A., Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 79 (2008), 335–341.
25. Mounasamy, V., Fulco, P., Desai, P., Adelaar, R., Bearman, G., The successful use of vancomycin-impregnated cement beads in a patient with vancomycin systemic toxicity: a case report with review of literature. Eur J Orthop Surg Traumatol 23 (2013), S299–S302.
26. Dunbar, M.J., Antibiotic bone cements: their use in routine primary total joint arthroplasty is justified. Orthopedics, 32, 2009, 10.3928/01477447-20090728-20 [orthosupersite.com/view.asp?.rID=42849].
27. Coventry, M.B., Beckenbaugh, R.D., Nolan, D.R., et al. 2012 total hip arthroplasties. A study of postoperative course and early complications. J Bone Joint Surg Am 56 (1974), 273–284.
28. Fillingham, Y.A., Ramkumar, D.B., Jevsevar, D.S., Yates, A.J., Shores, P., Mullen, K., et al. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty 33 (2018), 3090–3098.
29. Irisson, E., Hémon, Y., Pauly, V., Parratte, S., Argenson, J.N., Kerbaul, F., Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res 98 (2012), 477–483.
30. Touzopoulos, P., Ververidis, A., Mpogiatzis, C., Chatzigiannakis, A., Drosos, G.I., The use of tourniquet may influence the cement mantle thickness under the tibial implant during total knee arthroplasty. Eur J Orthop Surg Traumatol 29 (2019), 869–875.
31. Hsu, C.H., Lin, P.C., Kuo, F.C., Wang, J.W., A regime of two intravenous injections of tranexamic acid reduces blood loss in minimally invasive total hip arthroplasty: a prospective randomised double-blind study. Bone Joint J 97 (2015), 905–910.
32. Zhang, P., Liang, Y., Chen, P., Fang, Y., He, J., Wang, J., Intravenous versus topical tranexamic acid in primary total hip replacement: a meta-analysis. Medicine, 95, 2016, e5573.
33. Dao, P., Massin, P., Blood management in enhanced recovery after hip and knee replacement. Orthop Traumatol Surg Res 106 (2020), S1–S5.
34. King, L., Randle, R., Dare, W., Bernaitis, N., Comparison of oral vs. combined topical/intravenous/oral tranexamic acid in the prevention of blood loss in total knee arthroplasty: a randomised clinical trial. Orthop Traumatol Surg Res 105 (2019), 1073–1077.
35. Carvalho, L.H. Jr., Frois Temponi, E., Machado Soares, L.F., Gonçalves, M.B., Paiva Costa, L., Tavares de Souza, M.L., Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study. Orthop Traumatol Surg Res 101 (2015), 83–87.
36. Sun, X., Dong, Q., Zhang, Y.G., Intravenous versus topical tranexamic acid in primary total hip replacement: a systemic review and meta-analysis. Int J Surg 32 (2016), 10–18.
37. Meena, S., Benazzo, F., Dwivedi, S., Ghiara, M., Topical versus intravenous tranexamic acid in total knee arthroplasty. J Orthop Surg, 25, 2017 [2309499016684300].